Akston Biosciences
  • Programs
    • Pipeline
    • Platform
    • Process
  • Company
    • Overview
    • Leadership
    • Facilities
    • Partners
    • Contact
  • Careers
    • Overview
    • Career Opportunities
    • Our Culture
    • Contact
  • News
    • Overview
    • In The News
    • Press Releases
    • Papers

In The News

7 September 2022

Akston starts small and likes it that way

Director's Talk Interviews

5 September 2022

Dechra Pharmaceuticals achieves strong organic growth in all key markets

1 July 2022

Why Indian Pharma Must Evolve As ‘Value Creator’?

24 June 2022

Strides Pharma jumps on positive outcome of COVID-19 vaccine trials

1 June 2022

Akston Biosciences raising up to USD 10m to advance COVID-19 vaccine and other products, CEO says

21 April 2022

Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up

Analist.nl

13 April 2022

Getting through the Corona pandemic with AKS-452 vaccines

12 April 2022

Achieving Vaccine Equality is Key to Overcoming Covid

7 April 2022

COVID-19 vaccine: Akston Biosciences doses first volunteers in Phase II/III trial

18 March 2022

Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?

Posts navigation

1 2 3 … 5 »

Akston BioSciences

info@akstonbio.com |

  • Home
  • Company
  • Pipeline
  • Careers
  • Press Releases
  • Contact

©2023 Akston Biosciences Corporation